Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Invitrogen buys DNA Research Innovations for up to $65mm

Executive Summary

To fill a gap in its nucleic purification product offerings, Invitrogen (functional genomics, proteomics, bioinformatics, and cell biology kits) is acquiring privately held DNA purification company DNA Research Innovations Ltd. for $35mm in cash up front and potential earn-outs of up to $30mm.
Deal Industry
  • Research, Analytical Equipment & Supplies
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register